UBS has adjusted its stance on Bossard, moving the Swiss industrial fastener distributor from a "sell" rating to "neutral" and lifting its price target to CHF156 from CHF145. The brokerage framed the change as a recognition that the company’s present market value already reflects its conservative growth outlook, creating what it describes as a "more balanced risk/reward" profile.
Market reaction and valuation
Shares of Bossard rose 4.2% at 06:40 ET (10:40 GMT) following the report. UBS underlined that its moderate growth assumptions are largely baked into the share price. Using a reverse discounted cash flow methodology, the firm concluded that the current quote "incorporates also much of our rather unambitious expectations."
Near-term demand and tariff effects
UBS expects near-term underlying demand prospects to be muted. The brokerage expects only temporary support from tariff pass-throughs related to U.S.-focused aluminum and steel tariffs. Those tariff-driven benefits are projected to fade by the third quarter of 2026, limiting their contribution to longer-term growth.
Growth and margin forecasts
UBS models low single-digit organic sales growth across the near and medium term. Specifically, the firm forecasts an organic sales compound annual growth rate of roughly 3% for 2026-2030, compared with the company’s trailing decade organic sales CAGR of 3%-4%.
On a revenue basis, UBS projects sales to increase to CHF1.11 billion in 2026 from CHF1.07 billion in 2025, rising further to CHF1.20 billion by 2029. Operating profit (EBIT) is forecast to climb to CHF115 million in 2026 from CHF107 million in 2025.
Margin expansion is expected to be limited. UBS forecasts EBIT margins of 10.6% by 2030, up from an estimated 10% in 2025 but still below the prior peak of 12.4% recorded in 2021. The report notes that this trajectory "limits the margin support from operating leverage," resulting in only "marginal operating margin expansion over time."
Relative valuation and historical context
Based on Bossard’s latest closing price, UBS calculates an enterprise value-to-EBITDA multiple of about 9.8x, which it says is broadly in line with the company’s fifteen-year average.
Revisions following Q1 2026
UBS revised estimates after stronger-than-expected first-quarter 2026 sales. The brokerage raised its sales forecasts for 2026, 2027 and 2028 by 3%, 3% and 2%, respectively. Corresponding EBIT forecasts were increased by 4% for 2026 and by 3% for both 2027 and 2028.
Despite these upward adjustments, UBS said it would require further evidence that Bossard can sustainably return to its prior growth trajectory before adopting a more positive stance on the shares.
Key implications
- Valuation appears to reflect conservative growth expectations, limiting upside absent renewed growth momentum.
- Tariff-driven input cost pass-throughs offer only temporary support and are expected to diminish by Q3 2026.
- Margins are projected to improve only modestly, constraining operating-leverage benefits.